Dunstan DE - Search Results

1

The potential role of free chitosan in bone trauma and bone cancer management.

Tan ML, Shao P, Friedhuber AM, van Moorst M, Elahy M, Indumathy S, Dunstan DE, Wei Y, Dass CR. Tan ML, et al. Among authors: dunstan de. Biomaterials. 2014 Sep;35(27):7828-38. doi: 10.1016/j.biomaterials.2014.05.087. Epub 2014 Jun 17. Biomaterials. 2014. PMID: 24947230

2

Biocompatible chitosan-DNAzyme nanoparticle exhibits enhanced biological activity.

Dass CR, Friedhuber AM, Khachigian LM, Dunstan DE, Choong PF. Dass CR, et al. Among authors: dunstan de. J Microencapsul. 2008 Sep;25(6):421-5. doi: 10.1080/02652040802033673. J Microencapsul. 2008. PMID: 18465314

3

A chitosan-dipotassium orthophosphate hydrogel for the delivery of Doxorubicin in the treatment of osteosarcoma.

Ta HT, Dass CR, Larson I, Choong PF, Dunstan DE. Ta HT, et al. Among authors: dunstan de. Biomaterials. 2009 Jul;30(21):3605-13. doi: 10.1016/j.biomaterials.2009.03.022. Epub 2009 Apr 5. Biomaterials. 2009. PMID: 19345993

4

A chitosan hydrogel delivery system for osteosarcoma gene therapy with pigment epithelium-derived factor combined with chemotherapy.

Ta HT, Dass CR, Larson I, Choong PF, Dunstan DE. Ta HT, et al. Among authors: dunstan de. Biomaterials. 2009 Sep;30(27):4815-23. doi: 10.1016/j.biomaterials.2009.05.035. Epub 2009 Jun 7. Biomaterials. 2009. PMID: 19505719

5

The performance of doxorubicin encapsulated in chitosan-dextran sulphate microparticles in an osteosarcoma model.

Tan ML, Friedhuber AM, Dunstan DE, Choong PF, Dass CR. Tan ML, et al. Among authors: dunstan de. Biomaterials. 2010 Jan;31(3):541-51. doi: 10.1016/j.biomaterials.2009.09.069. Epub 2009 Oct 17. Biomaterials. 2010. PMID: 19836833

6

Chitosan microparticles encapsulating PEDF plasmid demonstrate efficacy in an orthotopic metastatic model of osteosarcoma.

Dass CR, Contreras KG, Dunstan DE, Choong PF. Dass CR, et al. Among authors: dunstan de. Biomaterials. 2007 Jul;28(19):3026-33. doi: 10.1016/j.biomaterials.2007.03.016. Epub 2007 Mar 18. Biomaterials. 2007. PMID: 17408737

7

Injectable chitosan hydrogels for localised cancer therapy.

Ta HT, Dass CR, Dunstan DE. Ta HT, et al. Among authors: dunstan de. J Control Release. 2008 Mar 20;126(3):205-16. doi: 10.1016/j.jconrel.2007.11.018. Epub 2008 Jan 12. J Control Release. 2008. PMID: 18258328 Review.

8

Downregulation of c-jun results in apoptosis-mediated anti-osteosarcoma activity in an orthotopic model.

Dass CR, Friedhuber AM, Khachigian LM, Dunstan DE, Choong PF. Dass CR, et al. Among authors: dunstan de. Cancer Biol Ther. 2008 Jul;7(7):1033-6. doi: 10.4161/cbt.7.7.6037. Epub 2008 Apr 4. Cancer Biol Ther. 2008. PMID: 18414033

9

Osteosarcoma treatment: state of the art.

Ta HT, Dass CR, Choong PF, Dunstan DE. Ta HT, et al. Among authors: dunstan de. Cancer Metastasis Rev. 2009 Jun;28(1-2):247-63. doi: 10.1007/s10555-009-9186-7. Cancer Metastasis Rev. 2009. PMID: 19214708 Review.

10

Chitosan-dibasic orthophosphate hydrogel: a potential drug delivery system.

Ta HT, Han H, Larson I, Dass CR, Dunstan DE. Ta HT, et al. Among authors: dunstan de. Int J Pharm. 2009 Apr 17;371(1-2):134-41. doi: 10.1016/j.ijpharm.2009.01.018. Int J Pharm. 2009. PMID: 19340925

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

62 results

Search Page